{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:46:30Z","timestamp":1794329190605,"version":"4.9.0"},"reference-count":142,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Myelodysplastic syndrome (MDS) is a common hematological malignant disease, characterized by malignant hematopoietic stem cell proliferation in the bone marrow (BM); clinically, it mainly manifests clinically mainly by as pathological hematopoiesis, hemocytopenia, and high-risk transformation to acute leukemia. Several studies have shown that the BM microenvironment plays a critical role in the progression of MDS. In this study, we specifically evaluated mesenchymal stromal cells (MSCs) that exert immunomodulatory effects in the BM microenvironment. This immunomodulatory effect occurs through direct cell-cell contact and the secretion of soluble cytokines or micro vesicles. Several researchers have compared MSCs derived from healthy donors to low-risk MDS-associated bone mesenchymal stem cells (BM-MSCs) and have found no significant abnormalities in the MDS-MSC phenotype; however, these cells have been observed to exhibit altered function, including a decline in osteoblastic function. This altered function may promote MDS progression. In patients with MDS, especially high-risk patients, MSCs in the BM microenvironment regulate immune cell function, such as that of T cells, B cells, natural killer cells, dendritic cells, neutrophils, myeloid-derived suppressor cells (MDSCs), macrophages, and Treg cells, thereby enabling MDS-associated malignant cells to evade immune cell surveillance. Alterations in MDS-MSC function include genomic instability, microRNA production, histone modification, DNA methylation, and abnormal signal transduction and cytokine secretion.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1078421","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T04:49:48Z","timestamp":1670388588000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Likun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.233320","article-title":"Myelodysplastic syndrome patient-derived xenografts: From no options to many","volume":"105","author":"C\u00f4me","year":"2020","journal-title":"Haematologica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41586-021-03548-6","article-title":"Lineage tracing of human development through somatic mutations","volume":"595","author":"Spencer Chapman","year":"2021","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2016-0008","article-title":"Mutant IDH: a targetable driver of leukemic phenotypes linking metabolism, epigenetics and transcriptional regulation","volume":"8","author":"Francine","year":"2016","journal-title":"Epigenomics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1618-0","article-title":"Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis","volume":"574","author":"Yoshimi","year":"2019","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4252\/wjsc.v2.i4.67","article-title":"Mesenchymal stem cells: Molecular characteristics and clinical applications","volume":"2","author":"Rastegar","year":"2010","journal-title":"World J Stem Cells"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162941","article-title":"Endothelial progenitor cell infusion induces hematopoietic stem cell reconstitution in vivo","volume":"113","author":"Salter","year":"2009","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2005.11.002","article-title":"The role of mesenchymal stem cells in haemopoiesis","volume":"20","author":"Dazzi","year":"2006","journal-title":"Blood Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2969","article-title":"Vascular niche e-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance","volume":"18","author":"Winkler","year":"2012","journal-title":"Nat Med"},{"key":"B14","first-page":"49","article-title":"The bone marrow stem stromal imbalance\u2013a key feature of disease progression in case of myelodysplastic mouse model","volume":"5","author":"Das","year":"2010","journal-title":"J Stem Cells"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01419.x","article-title":"Effective ex vivo expansion of hematopoietic stem cells using osteoblast-differentiated mesenchymal stem cells is CXCL12 dependent","volume":"84","author":"Mishima","year":"2010","journal-title":"Eur J Haematol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature10783","article-title":"Endothelial and perivascular cells maintain haematopoietic stem cells","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/stem.269","article-title":"Mesenchymal stromal cells: Current understanding and clinical status","volume":"28","author":"Salem","year":"2010","journal-title":"Stem Cells"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8012716","article-title":"Phenotypic\u2002and\u2002Cytogenetic\u2002Characterization\u2002of\u2002Mesenchymal stromal Cells\u2002in\u2002De novo myelodysplastic syndromes","volume":"2016","author":"Rathnayake","year":"2016","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V122.21.1560.1560","article-title":"CD271+ mesenchymal stromal cell density is high in poor-risk MDS and independently predicts overall survival","volume":"122","author":"Johnson","year":"2013","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12385","article-title":"Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53\/p21 pathway in myelodysplastic syndromes","volume":"93","author":"Fei","year":"2014","journal-title":"Eur J Haematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1309\/AJCP71OPHKOTLSUG","article-title":"Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival","volume":"142","author":"Johnson","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.083972","article-title":"Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide","volume":"98","author":"Ferrer","year":"2013","journal-title":"Hematologica"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2013.0283","article-title":"Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway","volume":"23","author":"Pavlaki","year":"2014","journal-title":"Stem Cells Dev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exphem.2015.10.005","article-title":"Impairment of PI3K\/AKT and WNT\/\u03b2-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes","volume":"44","author":"Falconi","year":"2016","journal-title":"Exp Hematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.186734","article-title":"Transforming growth factor beta1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia","volume":"103","author":"Geyh","year":"2018","journal-title":"Haematologica"},{"key":"B27","article-title":"Premature\u2002exhaustion\u2002of\u2002mesenchymal stromal cells\u2002from\u2002myelodysplastic syndrome patients","volume":"9","author":"Pang","year":"2017","journal-title":"Am J Transl Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.054437","article-title":"Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients","volume":"97","author":"Santamar\u00eda","year":"2012","journal-title":"Haematologica"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1177\/0963689717745890","article-title":"Aging - and senescence -associated changes of mesenchymal stromal cells in myelodysplastic syndromes","volume":"27","author":"Mattiucci","year":"2018","journal-title":"Cell Transplant"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0267-x","article-title":"Activation of NF-\u03baB driven inflammatory programs in mesenchymal elements attenuates hematopoiesis in low-risk myelodysplastic syndromes","volume":"33","author":"Ping","year":"2019","journal-title":"Leukemia"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.193","article-title":"Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells","volume":"27","author":"Geyh","year":"2013","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-013-1565-6","article-title":"Impaired osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with lower-risk myelodysplastic syndromes","volume":"35","author":"Fei","year":"2014","journal-title":"Tumour Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.172726","article-title":"Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical wnt pathway","volume":"103","author":"Balaian","year":"2018","journal-title":"Haematologica"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155438","article-title":"Mesenchymal stem cells in aplastic anemia and myelodysplastic syndromes: The \u201cSeed and soil\u201d crosstalk","volume":"21","author":"Fattizzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.12.016","article-title":"Impairment in immuno-modulatory function of Flk1(+)CD31(\u2013)CD34(\u2013) MSCs from MDS-RA patients","volume":"31","author":"Han","year":"2007","journal-title":"Leuk Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2009.0286","article-title":"Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes","volume":"19","author":"Klaus","year":"2010","journal-title":"Stem Cells Dev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15548","article-title":"Mesenchymal COX2-PG secretome engages NR4A-WNT signalling axis in haematopoietic progenitors to suppress anti-leukaemia immunity","volume":"183","author":"Wu","year":"2018","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097256","article-title":"SOCS1 regulates the immune modulatory properties of mesenchymal stem cells by inhibiting nitric oxide production","volume":"9","author":"Zhang","year":"2014","journal-title":"PLo S One"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2017.09.008","article-title":"Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing","volume":"62","author":"Azuma","year":"2017","journal-title":"Leuk Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.1038\/s41467-021-26424-3","article-title":"Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo","volume":"12","author":"Jann","year":"2021","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nature12883","article-title":"Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts","volume":"506","author":"Kode","year":"2014","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.91","article-title":"Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-Context-Dependent activation of inflammatory programs","volume":"30","author":"Chen","year":"2016","journal-title":"Leukemia"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukemia","volume":"8","author":"Marc","year":"2010","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2020.618308","article-title":"Mesenchymal stromal cells as a cellular target in myeloid malignancy: Chances and challenges in the genome editing of stromal alterations","volume":"2","author":"Bella","year":"2020","journal-title":"Front Genome Ed"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0282","article-title":"Epigenetically aberrant stroma in MDS propagates disease Via wnt\/\u03b2-catenin activation","volume":"77","author":"Tushar","year":"2017","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.02.009","article-title":"Stroma-mediated dysregulation of myelopoiesis in mice lacking I kappa b alpha","volume":"22","author":"Rudolf","year":"2005","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0310-y","article-title":"Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy","volume":"33","author":"Poon","year":"2019","journal-title":"Leukemia"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2014.02.014","article-title":"Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit","volume":"14","author":"Medyouf","year":"2014","journal-title":"Cell Stem Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.060312","article-title":"Hematopoietic stem cells: The paradigmatic tissue-specific stem cell","volume":"169","author":"Bryder","year":"2006","journal-title":"Am J Pathol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17071009","article-title":"Mesenchymal\u2002Stem\u2002and\u2002Progenitor Cells\u2002in\u2002Normal\u2002and\u2002Dysplastic\u2002Hematopoiesis\u2013masters of\u2002Survival\u2002and\u2002Clonality","volume":"17","author":"Pleyer","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-011-0075-y","article-title":"Stem cell interactions in a bone marrow niche","volume":"9","author":"Isern","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.48","article-title":"The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites","volume":"22","author":"Shiozawa","year":"2008","journal-title":"Leukemia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.htct.2019.12.002","article-title":"5-Azacytidine\u2002restores\u2002interleukin\u20026-increased\u2002production\u2002in\u2002mesenchymal stromal cells\u2002from\u2002myelodysplastic\u2002patients","volume":"43","author":"Boada","year":"2021","journal-title":"Hematol Transfus Cell Ther"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018022053","article-title":"Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis","volume":"2","author":"Catharina","year":"2018","journal-title":"Blood Adv"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146722","article-title":"Microvesicles from mesenchymal stromal cells are involved in HPC-microenvironment crosstalk in myelodysplastic patients","volume":"11","author":"Munti\u00f3n","year":"2016","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6493241","article-title":"Mesenchymal stem cell-derived microvesicles support ex vivo expansion of cord blood-derived CD34+ cells","volume":"2016","author":"Xie","year":"2016","journal-title":"Stem Cells Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.11.003","article-title":"Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo","volume":"12","author":"Zhao","year":"2007","journal-title":"Cancer Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2015.04.001","article-title":"Endothelial progenitor cell dysfunction in myelodysplastic syndromes: Possible contribution of a defective vascular niche to myelodysplasia","volume":"17","author":"Teofili","year":"2015","journal-title":"Neoplasia"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nature08099","article-title":"Bone marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2730","article-title":"Quantitative imaging of hematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment","volume":"15","author":"Nombela-Arrieta","year":"2013","journal-title":"Nat Cell Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.5045\/br.2016.51.4.225","article-title":"Mesenchymal stromal cells in myeloid malignancies","volume":"51","author":"Schroeder","year":"2016","journal-title":"Blood Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-020-00623-7","article-title":"Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche","volume":"4","author":"Krohn-Grimberghe","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"B63","first-page":"995","article-title":"Development and characterization of a melphalan-resistant human multiple myeloma cell line","volume":"51","author":"Bellamy","year":"1991","journal-title":"Cancer Res"},{"key":"B64","article-title":"Mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate","volume":"63","author":"Goldie","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/science.247.4949.1457","article-title":"Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo","volume":"247","author":"Teicher","year":"1990","journal-title":"Science"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.5.1658","article-title":"Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines","volume":"93","author":"Damiano","year":"1999","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-2223","article-title":"The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance","volume":"14","author":"Meads","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209164","article-title":"\u03b2 1-Integrin-Mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury","volume":"25","author":"Cordes","year":"2006","journal-title":"Oncogene"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-060350","article-title":"Cell adhesion induces P27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin b-cell lymphomas","volume":"110","author":"Lwin","year":"2007","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3614","article-title":"Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes","volume":"6","author":"Alonso","year":"2015","journal-title":"Oncotarget"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00106","article-title":"Mesenchymal stem cells support survival and proliferation of primary human acute myeloid leukemia cells through heterogeneous molecular mechanisms","volume":"8","author":"Brenner","year":"2017","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-655860","article-title":"Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy","volume":"128","author":"Moschoi","year":"2016","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-772939","article-title":"NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts","volume":"130","author":"Marlein","year":"2017","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511527","article-title":"Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance","volume":"123","author":"Jacamo","year":"2014","journal-title":"Blood"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nature11926","article-title":"CXCL12 production by early mesenchymal progenitors is required","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-162123","article-title":"Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100","volume":"113","author":"Nervi","year":"2009","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e45675","DOI":"10.1371\/journal.pone.0045675","article-title":"The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes","volume":"7","author":"Zhao","year":"2012","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-019-02420-x","article-title":"Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression","volume":"68","author":"Montes","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.637725","article-title":"Immunomodulatory properties of mesenchymal stromal cells: An update","volume":"9","author":"M\u00fcller","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132788","article-title":"Myeloid-derived suppressor cells and mesenchymal Stem\/Stromal cells in myeloid malignancies","volume":"10","author":"Kapor","year":"2021","journal-title":"J Clin Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2008.80","article-title":"A critical role of IFN[gamma] in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1","volume":"18","author":"Sheng","year":"2008","journal-title":"Cell Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2007.11.014","article-title":"Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide","volume":"2","author":"Ren","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: Inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802455875","article-title":"Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases","volume":"49","author":"Zhi-Gang","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-002246","article-title":"Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells","volume":"109","author":"Sato","year":"2007","journal-title":"Blood"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2016.0207","article-title":"Mechanisms of immune suppression utilized by canine adipose and bone marrow-derived mesenchymal stem cells","volume":"26","author":"Chow","year":"2017","journal-title":"Stem Cells Dev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000082540.43730.80","article-title":"Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells","volume":"76","author":"Rasmusson","year":"2003","journal-title":"Transplantation"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3696","article-title":"Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells","volume":"105","author":"Glennie","year":"2005","journal-title":"Blood"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.7150\/thno.21072","article-title":"Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis","volume":"8","author":"Cosenza","year":"2018","journal-title":"Theranostics"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030580","article-title":"Immune dysfunction, cytokine disruption, and stromal changes in myelodysplastic syndrome: A review","volume":"11","author":"Lynch","year":"2022","journal-title":"Cells"},{"key":"B92","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3324\/haematol.13612","article-title":"Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome","volume":"94","author":"Chamuleau","year":"2009","journal-title":"Haematologica"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035519","article-title":"Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors","volume":"109","author":"Epling-Burnette","year":"2007","journal-title":"Blood"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.130155","article-title":"Mesenchymal stromal cells shape the MDS microenvironment by inducing suppressive monocytes that dampen NK cell function","volume":"5","author":"Sarhan","year":"2020","journal-title":"JCI Insight"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02357","article-title":"Natural killer cells in myeloid malignancies: Immune surveillance, NK cell dysfunction, and pharmacological opportunities to bolster the endogenous NK cells","volume":"10","author":"Carlsten","year":"2019","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.149","article-title":"Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome","volume":"24","author":"Carlsten","year":"2010","journal-title":"Leukemia"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.333","article-title":"Kinetics, function and bone marrow trafficking of CD4 + CD25 + FOXP3+ regulatory T cells in myelodysplastic syndromes (MDS)","volume":"23","author":"Kotsianidis","year":"2009","journal-title":"Leukemia"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-067546","article-title":"CD4+ CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)","volume":"110","author":"Kordasti","year":"2007","journal-title":"Blood"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401776","article-title":"Conversion of Th17 into IL-17Aneg regulatory T cells: A novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell\u2013supported minimized immunosuppressive therapy","volume":"193","author":"Obermajer","year":"2014","journal-title":"J Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2016.12.001","article-title":"Mesenchymal stem cells overexpressing IL-35 effectively inhibit CD4+ T cell function","volume":"312","author":"Zhao","year":"2017","journal-title":"Cell Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yexcr.2014.03.013","article-title":"Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism","volume":"324","author":"Yan","year":"2014","journal-title":"Exp Cell Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03874.x","article-title":"Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells","volume":"156","author":"English","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-005-0048-z","article-title":"Role of immature myeloid cells in mechanisms of immune evasion in cancer","volume":"55","author":"Kusmartsev","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.11.002","article-title":"Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway","volume":"442","author":"De Veirman","year":"2019","journal-title":"Cancer Lett"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.599098","article-title":"Actors on the scene: Immune cells in the myeloma niche","volume":"10","author":"Leone","year":"2020","journal-title":"Front Oncol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07593.x","article-title":"IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome","volume":"145","author":"Kordasti","year":"2009","journal-title":"Br J Haematol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e1062208","DOI":"10.1080\/2162402X.2015.1062208","article-title":"Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome","volume":"5","author":"Kittang","year":"2015","journal-title":"Oncoimmunology"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1817431","article-title":"Increased myeloid-derived suppressor cells in patients with myelodysplastic syndromes suppress CD8+ T lymphocyte function through the STAT3-ARG1 pathway","volume":"62","author":"Qi","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2013.06.006","article-title":"Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor\/c-met and STAT3","volume":"1","author":"Yen","year":"2013","journal-title":"Stem Cell Rep"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01371","article-title":"Myeloid-derived suppressor cells in tumors: From mechanisms to antigen specificity and microenvironmental regulation","volume":"11","author":"Yang","year":"2020","journal-title":"Front Immunol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-0843-1","article-title":"Myeloid-derived suppressor cells-new and exciting players in lung cancer","volume":"13","author":"Yang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01680","article-title":"The new era of cancer immunotherapy: Targeting myeloid-derived suppressor cells to overcome immune evasion","volume":"11","author":"De Cicco","year":"2020","journal-title":"Front Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"Chouaib s. PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e1247135.61","DOI":"10.1080\/2162402X.2016.1247135","article-title":"The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells","volume":"5","author":"Lu","year":"2016","journal-title":"Oncoimmunology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-01-829663","article-title":"Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell en-graftment","volume":"132","author":"Kaur","year":"2018","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3057","article-title":"CD169+ macrophages provide a niche promoting erythropoiesis under homeostasis and stress","volume":"19","author":"Chow","year":"2013","journal-title":"Nat Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-012-9495-y","article-title":"Angiogenesis and survival in patients with myelodysplastic syndrome","volume":"18","author":"Savic","year":"2012","journal-title":"Pathol Oncol Res"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00913.x","article-title":"Immunohistochemical assessment of human bone marrow macrophages in hematologic disorders","volume":"49","author":"Sadahira","year":"1999","journal-title":"Pathol Int"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08683.x","article-title":"Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: Implications for immunotherapy","volume":"153","author":"Aggarwal","year":"2011","journal-title":"Br J Haematol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.blre.2019.04.004","article-title":"Flaming and fanning: The spectrum of inflammatory influences in myelodysplastic syndromes","volume":"36","author":"Banerjee","year":"2019","journal-title":"Blood Rev"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.04.040","article-title":"Rhythmic modulation of the hematopoietic niche through neutrophil clearance","volume":"153","author":"Casanova-Acebes","year":"2013","journal-title":"Cell"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124213","article-title":"Aged marrow macrophages expand platelet-biased hematopoietic stem cells via Interleukin1B","volume":"5","author":"Frisch","year":"2019","journal-title":"JCI Insight"},{"key":"B127","doi-asserted-by":"publisher","first-page":"16214","DOI":"10.1038\/s41598-017-15376-8","article-title":"Mesenchymal stem cells derived exosomes and microparticles protect cartilage and bone from degradation in osteoarthritis","volume":"7","author":"Cosenza","year":"2017","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5126156","article-title":"Stem cell-derived extracellular vesicles as immunomodulatory therapeutics","volume":"2019","author":"Seo","year":"2019","journal-title":"Stem Cells Int"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2217\/imt.13.51","article-title":"Dendritic cells in myelodys-plasticsyndromes: From pathogenesis to immunotherapy","volume":"5","author":"Kerkhoff","year":"2013","journal-title":"Immunotherapy"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2012.10.010","article-title":"Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes","volume":"37","author":"Saft","year":"2013","journal-title":"Leuk Res"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2921","article-title":"Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness","volume":"105","author":"Beyth","year":"2005","journal-title":"Blood"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403430","article-title":"Circulating myeloid and lymphoid precursor dendritic cells are clonally involved in myelodysplastic syndromes","volume":"18","author":"Ma","year":"2004","journal-title":"Leukemia"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900328","article-title":"Bone marrow monocytes and derived dendritic cells from myelodysplastic patients have functional abnormalities associated with defective response to bacterial infection","volume":"204","author":"Bento","year":"2020","journal-title":"J Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600622","article-title":"Mechanisms of impaired neutrophil migration by MicroRNAs in myelodysplastic syndromes","volume":"198","author":"Cao","year":"2017","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/srep29955","article-title":"Tumourigenicity and immunogenicity of induced neural stem cell grafts versus induced pluripotent stem cell grafts in syngeneic mouse brain","volume":"6","author":"Gao","year":"2016","journal-title":"Sci Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"20780","DOI":"10.4172\/2157-7633.S6-001","article-title":"Human bone marrow- and adipose tissue-derived mesenchymal stromal cells are immunosuppressive In vitro and in a humanized allograft rejection model","author":"Roemeling-van Rhijn","year":"2013","journal-title":"J Stem Cell Res Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1080\/14653240903193806","article-title":"Mesenchymal stem cells in hematopoietic stem cell transplantation","volume":"11","author":"Battiwalla","year":"2009","journal-title":"Cytotherapy"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10121065","article-title":"Extracellular vesicles in hematological malignancies: From biomarkers to therapeutic tools","volume":"10","author":"Khalife","year":"2020","journal-title":"Diagnostics"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: A new approach for drug delivery","volume":"192","author":"Pascucci","year":"2014","journal-title":"J Control Release"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.90","article-title":"Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis","volume":"24","author":"Wang","year":"2016","journal-title":"Mol Ther"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-017-0116-9","article-title":"Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379","volume":"37","author":"O\u2019Brien","year":"2018","journal-title":"Oncogene"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1078421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T04:49:53Z","timestamp":1670388593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1078421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":142,"alternative-id":["10.3389\/fimmu.2022.1078421"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1078421","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,7]]},"article-number":"1078421"}}